Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeev Estrov

Showing results (11-20 of 327) with videos related to

Pageof 33
Sort By:
Cancer|March 2, 2005
Metastasis--an alternative hypothesisEmil J Freireich, Razelle Kurzrock, Zeev Estrov
Critical Reviews in Oncology/Hematology|August 15, 2013
Targeting inflammatory pathways in chronic lymphocytic leukemiaUri Rozovski, Michael J Keating, Zeev Estrov
Acta Haematologica|August 17, 2018
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?Uri Rozovski, Michael J Keating, Zeev Estrov
British Journal of Haematology|February 14, 2002
Cellular signalling pathways: new targets in leukaemia therapyFarhad Ravandi, Moshe Talpaz, Hagop Kantarjian, et al.
Leukemia Research|October 6, 2005
Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphomaL Jeffrey Medeiros, Zeev Estrov, George Z Rassidakis
Leukemia & Lymphoma|September 13, 2006
Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: implications for imatinib mesylate response and resistanceRazelle Kurzrock, Moshe Talpaz, Lan Li, et al.
Cancer|April 3, 2015
Meir Wetzler, MDRazelle Kurzrock, Zeev Estrov, Moshe Talpaz, et al.
British Journal of Haematology|June 13, 2002
Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remissionStefan Faderl, Peter F Thall, Hagop M Kantarjian, et al.
Cancer Letters|July 25, 2013
Personalized medicine in CLL: current status and future perspectivesUri Rozovski, Inbal Hazan-Halevy, Michael J Keating, et al.
American Journal of Hematology|August 29, 2018
Biclonal IGHV-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclaxPreetesh Jain, Rashmi Kanagal-Shamanna, Sergej Konoplev, et al.
Pageof 33

Showing results (11-20 of 327) with videos related to

Sort By:
Pageof 33
Cancer|March 2, 2005
Metastasis--an alternative hypothesisEmil J Freireich, Razelle Kurzrock, Zeev Estrov
Critical Reviews in Oncology/Hematology|August 15, 2013
Targeting inflammatory pathways in chronic lymphocytic leukemiaUri Rozovski, Michael J Keating, Zeev Estrov
Acta Haematologica|August 17, 2018
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?Uri Rozovski, Michael J Keating, Zeev Estrov
British Journal of Haematology|February 14, 2002
Cellular signalling pathways: new targets in leukaemia therapyFarhad Ravandi, Moshe Talpaz, Hagop Kantarjian, et al.
Leukemia Research|October 6, 2005
Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphomaL Jeffrey Medeiros, Zeev Estrov, George Z Rassidakis
Leukemia & Lymphoma|September 13, 2006
Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: implications for imatinib mesylate response and resistanceRazelle Kurzrock, Moshe Talpaz, Lan Li, et al.
Cancer|April 3, 2015
Meir Wetzler, MDRazelle Kurzrock, Zeev Estrov, Moshe Talpaz, et al.
British Journal of Haematology|June 13, 2002
Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remissionStefan Faderl, Peter F Thall, Hagop M Kantarjian, et al.
Cancer Letters|July 25, 2013
Personalized medicine in CLL: current status and future perspectivesUri Rozovski, Inbal Hazan-Halevy, Michael J Keating, et al.
American Journal of Hematology|August 29, 2018
Biclonal IGHV-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclaxPreetesh Jain, Rashmi Kanagal-Shamanna, Sergej Konoplev, et al.
Pageof 33